Frequency of pericardial effusion on COVID-19 patients in Rasht, Iran
DOI:
https://doi.org/10.61186/jcbior.5.2.255Keywords:
Pericardial Effusion, COVID-19, HRCT, EchocardiographyAbstract
Pericardial involvement is a rare extra-pulmonary manifestation of coronavirus disease 2019 (COVID-19). This study aimed to determine the frequency of pericardial effusion (PE) on patients with COVID-19. In this cross-sectional study, 582 patients with COVID-19 were investigated between March and May, 2020. Using high-resolution computed tomography (HRCT), patterns of pulmonary involvement and existence of PE were evaluated by a team including a radiologist, an emergency medicine specialist and a cardiologist. Other information such as laboratory tests, clinical symptoms, underlying comorbidities and a history of contact with COVID-19 patients was extracted from the patient’s records. A total of 582 COVID-19 cases were investigated, of which 350 (60.14%) cases were women and 232 (39.86%) cases were men. Mean age of patients was 60.38±16.12 years. The most common symptoms were cough (58.93%), myalgia (52.74%), sweating (49.31%) and fever (44.32%). Among 582 COVID-19 patients, 2.7% (16 cases) had PE (95% CI; -4.5-1.6). Furthermore, 81% of the patients had mild PE (95% CI; 1.57-3.89). Also, 92% of the patients with PE had underlying comorbidities. By comparison, 74.5% of the patients without PE had comorbidities (P=0.047). There was no significant difference in the pattern of pulmonary involvement between the patients with PE and without PE (P>0.05). Prevalence of PE in COVID-19 patients is low. Underlying comorbidities, respectively, HTN and DM and ischemic heart diseases play an important role in occurrence of PE in COVID-19 patients. Our study revealed that it is not necessary for all patients to undergo an echocardiography.
Downloads
References
1. Sadeghi Dousari A, Taati Moghadam M, Satarzadeh N. COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease. Infect Drug Resist. 2020;13:2819-28. DOI: 10.2147/IDR.S259279 PMID: 32848431
2. Akimkin VG. COVID-19 Epidemiology and Diagnosis: Monitoring Evolutionary Changes in the SARS-COV-2 Virus. Her Russ Acad Sci. 2022;92(4):392-7. DOI: 10.1134/S1019331622040013 PMID: 36091861
3. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. DOI: 10.1001/jamacardio.2020.1017 PMID: 32219356
4. Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106(15):1132-41. DOI: 10.1136/heartjnl-2020-317056 PMID: 32354800
5. Team CC-R. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382-6. DOI: 10.15585/mmwr.mm6913e2 PMID: 32240123
6. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27(3):308-17. DOI: 10.1097/HCO.0b013e3283524fbe PMID: 22450720
7. Asif T, Kassab K, Iskander F, Alyousef T. Acute pericarditis and cardiac tamponade in a patient with COVID-19: a therapeutic challenge. European J Case Report Inter Med. 2020;7(6):001701.
8. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608-16. DOI: 10.1161/CIRCULATIONAHA.105.543066 PMID: 16330703
9. Amoozgar B, Kaushal V, Mubashar U, Sen S, Yousaf S, Yotsuya M. Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report. Medicine (Baltimore). 2020;99(37):e22093. DOI: 10.1097/MD.0000000000022093 PMID: 32925751
10. Roy CL, Minor MA, Brookhart MA, Choudhry NK. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007;297(16):1810-8. DOI: 10.1001/jama.297.16.1810 PMID: 17456823
11. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186-97. DOI: 10.1093/eurheartj/ehs372 PMID: 23125278
12. Wang YY, Jin YH, Ren XQ, Li YR, Zhang XC, Zeng XT, et al. Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary. Mil Med Res. 2020;7(1):17. DOI: 10.1186/s40779-020-00245-9 PMID: 32245396
13. Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol. 2020;215(1):87-93. DOI: 10.2214/AJR.20.23034 PMID: 32174129
14. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. DOI: 10.1001/jama.2020.1585 PMID: 32031570
15. Huang P, Liu T, Huang L, Liu H, Lei M, Xu W, et al. Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion. Radiology. 2020;295(1):22-3. DOI: 10.1148/radiol.2020200330 PMID: 32049600
16. Wormanns D, Hamer OW. [Glossary of Terms for Thoracic Imaging--German Version of the Fleischner Society Recommendations]. Rofo. 2015;187(8):638-61. DOI: 10.1055/s-0035-1553216 PMID: 26218473
17. Muhammad SZ, Ahmed A, Shahid I, Khalid A, Menezes RG, Sheikh MU, et al. Chest computed tomography findings in hospitalized COVID-19 patients: a systematic review and meta-analysis. Infez Med. 2020;28(3):295-301.
18. Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M. Pericarditis in patients with COVID-19: a systematic review. J Cardiovasc Med (Hagerstown). 2021;22(9):693-700. DOI: 10.2459/JCM.0000000000001202 PMID: 33927144
19. Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020;55(6):327-31. DOI: 10.1097/RLI.0000000000000672 PMID: 32118615
20. Hu Q, Guan H, Sun Z, Huang L, Chen C, Ai T, et al. Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China. Eur J Radiol. 2020;128:109017. DOI: 10.1016/j.ejrad.2020.109017 PMID: 32387924
21. Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):1-23.
22. Rathore SS, Hussain N, Manju AH, Wen Q, Tousif S, Avendano-Capriles CA, et al. Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2022;94(1):229-39. DOI: 10.1002/jmv.27301 PMID: 34449896
23. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295(1):210-7. DOI: 10.1148/radiol.2020200274 PMID: 32027573
24. Abkhoo A, Shaker E, Mehrabinejad MM, Azadbakht J, Sadighi N, Salahshour F. Factors Predicting Outcome in Intensive Care Unit-Admitted COVID-19 Patients: Using Clinical, Laboratory, and Radiologic Characteristics. Crit Care Res Pract. 2021;2021:9941570. DOI: 10.1155/2021/9941570 PMID: 34306751
25. Zhan N, Guo Y, Tian S, Huang B, Tian X, Zou J, et al. Clinical characteristics of COVID-19 complicated with pleural effusion. BMC Infect Dis. 2021;21(1):176. DOI: 10.1186/s12879-021-05856-8 PMID: 33588779
26. Lazar M, Barbu EC, Chitu CE, Anghel AM, Niculae CM, Manea ED, et al. Pericardial Involvement in Severe COVID-19 Patients. Medicina (Kaunas). 2022;58(8). DOI: 10.3390/medicina58081093 PMID: 36013560
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
